Ironwood Pharmaceuticals, Inc. (IRWD) revenue

Revenue · fiscal 2025
$296.15M

Ironwood Pharmaceuticals, Inc. (IRWD) reported revenue of $296.15M in fiscal 2025 (the year ended December 31, 2025). That is 15.7% lower than the $351.41M of fiscal 2024. Figures as of 18 Nov 2026, 10:46 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$296.15M
Change on fiscal 2024
−15.7%
Growth, 5 years
−5.3% a year
Growth, 10 years
+7.1% a year
Highest on record
$442.74Mfiscal 2023
Lowest on record
$22.88Mfiscal 2013
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ironwood Pharmaceuticals, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 5.3% a year; over ten years the rate was 7.1% a year. Across the 17 fiscal years on record (2009–2025), the highest was $442.74M in fiscal 2023 and the lowest $22.88M in fiscal 2013.

History · 17 fiscal years

Revenue by fiscal year

Ironwood Pharmaceuticals, Inc. revenue, year by year

Ironwood Pharmaceuticals, Inc. (IRWD) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$296.15M 15.7% down
2024$351.41M 20.6% down
2023$442.74M 7.8% up
2022$410.60M 0.8% down
2021$413.75M 6.2% up
2020$389.52M 9.1% down
2019$428.41M 23.6% up
2018$346.64M 16.2% up
2017$298.28M 8.9% up
2016$273.96M 83.2% up
2015$149.56M 95.7% up
2014$76.44M 234.1% up
2013$22.88M 84.8% down
2012$150.25M 128.1% up
2011$65.87M 50.2% up
2010$43.86M 27.8% up
2009$34.32M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on IRWD

Ironwood Pharmaceuticals, Inc., figure by figure

Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard

Ironwood Pharmaceuticals, Inc. revenue: questions and answers

What is Ironwood Pharmaceuticals, Inc.'s revenue?

Ironwood Pharmaceuticals, Inc. (IRWD) reported revenue of $296.15M in fiscal 2025 (the year ended December 31, 2025). That is 15.7% lower than the $351.41M of fiscal 2024.

What is the growth rate of Ironwood Pharmaceuticals, Inc.'s revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 5.3% a year; over ten years the rate was 7.1% a year.

What are the highest and lowest revenue figures on record for Ironwood Pharmaceuticals, Inc.?

Across the 17 fiscal years on record (2009–2025), the highest was $442.74M in fiscal 2023 and the lowest $22.88M in fiscal 2013.

How is Ironwood Pharmaceuticals, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Ironwood Pharmaceuticals, Inc. it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.